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Abstract
Background: Eczema, asthma and hay fever are global health problems and their prevalence has increased
considerably over the last decades. All appear to share an underlying atopic diathesis but their aetiology is
considered to be multifactorial. They have been linked to decreases in health related quality of life (HRQoL) in
adults, children/adolescents and/or parents of children. Research also suggests an association of the three
conditions with mental health, which in turn is related to HRQoL decreases. We aimed to assess whether the
impact of any of the three conditions on HRQoL is modified by presence of mental health problems.
Methods: The impact of occurrence of the three conditions within the past four weeks and 12 months on HRQoL,
as measured by the ‘Quality of Life in Children – Revised’ (KINDL-R) questionnaire was analysed by use of the
complex sample general linear model in a population-based sample (N = 6518) of children and adolescents aged
11 – 17. Analyses were adjusted for the other atopic conditions, sociodemographic and clinical variables and
stratified for mental health as measured by the Strengths and Difficulties Questionnaire (SDQ) (normal n = 5697,
borderline n = 609, abnormal n = 193).
Results: Eczema and hay fever within the past four weeks were significantly associated with decreased total or
certain subscales of KINDL-R after adjusting for all other variables when no mental health abnormalities were
present while asthma was associated with better HRQoL in these individuals. However, when mental health
problems were present, eczema was positively associated with several subscales and the positive impact of asthma
was stronger. The presence of mental health problems accentuated the negative relationship between hay fever
and HRQoL (stronger negative impact). However, due to decreasing numbers in the group with mental health
problems only few associations reached statistical significance.
Conclusions: While the results suggest mental health to have a modifying effect on the relationship between
some atopic conditions and HRQoL caution needs to be exercised in interpreting the results: First, the groups with
borderline or abnormal mental health were comparably smaller than the group with normal mental health. In the
group with normal mental health small effects were more likely to become significant than in the other two
groups. Secondly some problems regarding the validity of the self-report SDQ still remain.
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Introduction
Atopic disease comprises the triad asthma, hay fever and
eczema (atopic dermatitis). All are common conditions
in paediatric practice [1]. Eczema is a very common in-
flammatory skin disease in children [1]. Its prevalence
has been found to have increased substantially in many
parts of the Western world, Asia and Africa [2] and its
12-month prevalence to be as high as 24% in some parts
of the world [3]. Asthma is a chronic inflammatory con-
dition of the lower airways characterised by recurrent
wheezing, breathlessness and coughing [4] Hay fever is a
chronic inflammatory condition of the upper airways
that can be described by rhinorrea, nasal itching and ob-
struction and sneezing [5]. The lifetime prevalence in
children aged 7 to 12 years may be as high as 28.4%
(asthma) and 26.5% (hay fever) [6] but there is also sub-
stantial global variation [7,8].
They appear to share a common aetiological under-
pinning, namely that any of the three conditions is as-
sumed to arise as a result of the interplay between the
inherited atopy (predisposition) and environmental fac-
tors [9]. There is also some evidence for the so-called
‘atopic march’. The term denotes the progression from
eczema to asthma and hay fever during adolescents’ de-
velopment [10].
While many advances have been made in terms of
identifying the multiple risk factors for the development
of any of the atopic diseases, their progression and
course, as well as curative and preventive interventions
they still comprise very common conditions in paediatric
practice [1] and have been consistently linked to de-
creases in health-related quality of life (HRQoL) [11-14].
Consequently, pediatric HRQOL has emerged as an im-
portant health outcome in clinical trials and healthcare
research [15]. Several studies have also observed an asso-
ciation of mental health problems with HRQoL [16-20].
A previous analysis [21] was able to show that several
domains of HRQoL were significantly impaired even
after control for mental health problems in children and
adolescents with eczema, asthma or hay fever. These
analyses also took atopic comorbidity into account, i.e.
controlled for the effects of other atopic disease on
HRQoL. This allowed capturing the impact of each sin-
gle condition independent of any existing atopic comor-
bidity and any mental health problems.
Due to the chronicity of atopic disease adequate adap-
tation appears necessary in several domains. Because the
ability to successfully adapt may vary as a function of
mental health it is plausible to expect a higher impact of
any disease but also atopic disease on HRQoL in individ-
uals with mental health problems. This higher impact
may be seen as the result of fewer perceived resources,
more perceived stress or less self-efficacy to name but a
few dimensions. Modifying effects of mental health on
the relationship between disease and HRQoL were dem-
onstrated for various chronic conditions [22-25]. Some
studies even showed that most of the impact of a
chronic condition on HRQoL was confined to cases with
co-morbid mental disorders [26]. However, no data is
available with respect to whether the level of HRQoL
impairment varies as a function of mental health prob-
lems in children and adolescents suffering from atopic
disease.
It was the aim of this analysis to examine whether the
impact of eczema, asthma and hay fever occurrence
(both within the past four weeks and the past 12
months) varies as a function of mental health status. It
was expected that the presence of mental health prob-
lems would lead to more pronounced impairments in
HRQoL across atopic disease but that acuteness (4-week
versus 12-month occurrence) would also be associated
with differential effects. A second aim was to identify
the HRQoL-areas which are particularly affected in
groups formed on the basis of mental health status.
Method
Design and participants
We analysed the public use files of the KiGGS (Health
Interview and Examination Survey for Children and
Adolescents) study [27]. The study was approved by the
Federal Office for Data Protection and by the ethics
committee of the university hospital Charité, Berlin [28].
KiGGS, which is a representative cross-sectional survey,
was conducted from 2003 to 2006 in 167 sampling units
(locations) in Germany. Within each sampling unit par-
ticipants were randomly selected from the local popula-
tion registries. From a total of 28,299 individuals invited
17,642 aged 0–17 years agreed to participate (response
rate: 66.6%). A detailed description of the two-stage
sampling method is provided elsewhere [29]. Of the 17,642
individuals taking part in the KiGGS, 6,813 were children
and adolescents aged 11 – 17 years. The present analyses
are based on 6,518 individuals for whom data on KINDL-R
(Quality of Life in Children - Revised [30,31] and the atopic
conditions was available. 2935 (45%) were aged 11 – 13
years and 3583 (45%) aged 14 – 17 years.
Instruments
Data from the KiGGS used in this investigation are
based on self-administered questionnaires completed by
parents/caregivers, computer assisted personal inter-
views (CAPI) with parents/caregivers and children/
adolescents’ self-reports of HRQoL. The CAPI was con-
ducted by physicians who were specifically trained for
the purposes of the study and, besides vaccination status
and medication use within the past 7 days, assessed the
history of selected physician-diagnosed conditions. If
parents gave their consent, a blood sample was taken.
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Using the system IMMUNOCAP (Phadia), specific IgE
was determined in those children aged 3–17 years for the
following antigenes: Dermatophagoides pteronyssinus,
Dermatophagoides farinae, cat dander, horse epithelium,
dog dander, egg white, peanut, soy bean, milk protein, car-
rot, potato, wheat flour, green apple, rice, rye pollen, tim-
othy grass pollen, Cladosporium herbarum, Aspergillus
fumigatus, birch pollen, mugwort pollen [32].
The 4-week and the 12-month prevalence of eczema,
asthma and hay fever/allergic conjunctivitis were based
on parents’ reports of a medical diagnosis made by a
physician within the past four weeks or 12 months, re-
spectively in the CAPI.
HRQoL was measured by the German KINDL-R ques-
tionnaire which contains 24 items [30]. Its psychometric
properties have been established [31]. Generic in nature
it measures the following six dimensions of quality of
life: Physical well-being (PWB), emotional well-being
(EWB), self-esteem (SE), family (quality of relationship
with family), friends (quality of relationship with
friends), and everyday-functioning (well-being at school).
The recall period is the past 7 days. It accounts for dif-
ferences in development by providing different versions
for different age groups. Items are scored on a 5-point
Likert scales (never, seldom, sometimes, often, always).
For each dimensions a total score can be computed by
adding the respective items forming that dimension. An
overall total KINDL-R score is computed by summing
all 24 items. All scores are transformed into values ran-
ging from 0 – 100. Larger scores denote better quality of
life. For the present analysis the self-report version of
the KINDL-R was used.
The database used for the present analyses further con-
tains information (assessed by parent report) on age in
years, gender (male vs. female), migration status (German
versus migration background), weight and height. The lat-
ter two were used to compute the Body-Mass-Index which
was used to classify overweight according to Krohmeyer-
Hausschild [33]. It further contains data (education, occu-
pation and family income) which is used to create the
composite socioeconomic status (SES; low, medium, high)
[34]. Finally, allergic sensitisation was operationalised as
yes (sensitization to at least one of the above food or
aero-allergens) or no. All analyses were adjusted for these
variables. Covariates were chosen based on evidence re-
garding their relationship with HRQoL and/or the atopic
conditions.
The self-report version of the Strengths and Difficul-
ties Questionnaire (SDQ) [35], a brief 25-item behav-
ioural screening questionnaire assessing emotional
symptoms, conduct problems, hyperactivity/inattention,
peer relationship problems and prosocial behaviour was
used to provide a measure of mental health (normal,
borderline, abnormal). Individual SDQ-items are scored
on a 3-point scale (0 not true, 1 somewhat true, and 2
certainly true); higher scores denote greater problems
except for prosocial behaviour, for which a higher score
is suggestive of more positive behaviour. All items apart
from the prosocial behaviour items are used to calculate
a total score (range 0 – 40) with higher scores indicating
more problematic behaviour. According to the cut-offs
provided [36] individuals are assigned to one of the
three groups (≤ 15 = normal, > 15 = borderline, > 19 =
abnormal mental health). Although the self-report
SDQ’s reliability and validity have been established
across cultures to some extent [37], it has to be noted
that the SDQ fares less well than a full clinical interview
in terms of validity [38].
Statistical analysis
Data was analysed using SPSS 20 (IBM Statistics). A
cluster variable was specified to account for non-
independence of observations within the 167 clusters
(sampling points) from which individuals were re-
cruited. This was done to give us greater confidence in
accepting a significant effect as being a population par-
ameter. Failing to model the design effect (clustering)
would lead to an underestimation of the respective
standard errors and thus lead to less valid conclusions
about the data. Data was also weighted according to a
weight factor correcting for deviations within the sam-
ple from the population structure in terms of age,
gender, region and nationality [29]. By doing so, the
findings become applicable to the population of
German children and adolescents at large. SPSS’ GLM
(General Linear Model) procedure for complex samples
was used to analyse the associations of the three condi-
tions with HRQoL in multivariate analysis within each
category of mental health status while controlling
for other atopic comorbidity, age, gender, ethnic
origin, socioeconomic status, overweight and allergic
sensitization. This procedure yields unstandardised Beta
coefficients (B). These can be interpreted as increments
in the dependent variable (in the original units of meas-
urement) in individuals in whom the condition is
present in comparison to those individuals in whom the
condition is not present holding all other variables
constant.
Results
Sociodemographic and clinical characteristics are dis-
played in Table 1. The epidemiological parameters of the
sample as well as the main effects of the three atopic
conditions on HRQoL are described in detail by
Matterne et al. [21]. In brief, the vast majority did not
show signs of mental health problems (SDQ = 0: 87.7%;
SDQ = 1: 9.5%; SDQ = 2: 2.8%) and the four-week
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prevalence of eczema was 4.3%, of asthma 2.4% and of
hay fever 5.1%.
Table 2 displays the results of the multivariate analyses
regressing eczema, asthma and hay fever (once within
the past 4 weeks and once within the past 12 months,
respectively) on total KINDL-R and its subscales’ scores
stratified by mental health and controlled for presence
of other atopic condition as well as age, gender, origin,
SES, overweight and allergic sensitisation.
Eczema within the past four weeks was significantly
associated with decreases in total KINDL-R scores when
no mental health abnormalities were present. Presence
of eczema in this group led to a 1.82 point decrease in
total HRQoL holding all other variables constant. Most
of this decrease was due to impairments in the physical
and self-worth (self-esteem) domain. With increasing
levels of mental health abnormalities no significant asso-
ciations of eczema within the past four weeks and
KINDL-R scores were observed apart from a significant
association of eczema with the family domain in the
group with mental health abnormalities. Here presence
of eczema led to a 10.44 point improvement in the
quality of the relationship with one’s family while con-
trolling for all other variables. Further, the relationship’s
direction was reversed in the group with abnormal men-
tal health for the total and four of the six subscales.
Asthma within the past four weeks was significantly
related to better well-being at school but no other sig-
nificant relationship was observed in the group with no
mental health abnormalities. No significant associations
with asthma within the past four weeks were observed
in the group with borderline or in the group with mental
health abnormalities.
In the group with no mental health abnormalities hay
fever within the past four weeks was significantly related
to reduced total KINDL-R scores and the impact was
mainly due to impairments in physical functioning. In
the group with mental health abnormalities, total and
subscale scores were consistently and markedly lower
compared to the group with no mental health abnor-
malities. However, a significant effect of hay fever on
KINDL-R scores was only found for emotional well-
being in this group. Hay fever within the past four weeks
reduced children’s emotional well-being by almost 20
points while controlling for all other variables.
With regard to the impact of the three atopic condi-
tions within the past 12 months on HRQoL it was obvi-
ous that the impact was less pronounced compared to
the 4-week occurrence and that consequently fewer as-
sociations reached significance. The only significant as-
sociations were observed for eczema on the family
relations subscale and of hay fever on total and the phys-
ical functioning subscale in the group with no mental
health abnormalities. The direction of association was
negative. No significant associations were detected in
the other two groups. However, similar to the 4-week
occurrence of eczema in the group with mental health
abnormalities the associations, albeit insignificant, were
reversed for total and four subscales’ scores of KINDL-R.
More impairment in total and three subscale scores was
observed for the group with mental health abnormalities
in comparison with the group with no mental health
problems but the differences were markedly lower com-
pared to the 4-week occurrence of hay fever.
Discussion
We aimed to assess whether the impact of any of the
three atopic conditions is modified by concurrent levels
of mental health problems. The rationale behind this
was to obtain information that can be taken into account
when evaluating the impact of any of the three condi-
tions on HRQoL in an individual. This may then lead to
different judgements as to what areas need to addition-
ally or particularly be targeted to help certain children
or adolescents to better come to terms with their atopic
condition(s).
The present analyses clearly revealed the associations of
any of the three atopic conditions on children and adoles-
cents’ HRQoL to vary as a function of mental health status.
However, only few of the relatively large effects in the
Table 1 Sample description: absolute and relative
frequencies of sociodemographic and clinical
characteristics (N = 6518)
n % %a 95% CI a
Age (n = 6518)
11 – 13 years 2935 45.0 39.7 38.8 40.5
14 – 17 years 3583 55.0 60.3 59.5 61.2
Gender (n = 6518)
Male 3326 51.0 51.1 50.7 51.4
Female 3192 49.0 48.9 48.6 49.3
Origin (n = 6517)
German 5530 84.9 83.0 80.7 85.1
Migration Background 987 15.1 17.0 14.9 19.3
SES (n = 6309)
Low 1697 26.9 27.2 25.7 28.7
Medium 3057 48.5 47.3 45.8 48.7
High 1555 24.6 25.6 23.9 27.3
Overweight (n = 6491)
Yes 1152 17.7 17.6 16.6 18.7
No 5339 82.3 82.4 81.3 83.4
Allergic Sensitisation (n = 6107)
Yes 2763 45.2 45.8 44.2 47.3
No 3344 54.8 54.2 52.7 55.8
SES Socioeconomic status, aweighted percentages simultaneously accounting
for nested structure (sampling points).
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group with abnormal mental health reached significance.
This is likely the result of the decreasing sample size corre-
sponding with increasing levels of mental health problems.
The sample size decreased from 5697 (no abnormalities),
to 609 (borderline) to 193 (abnormal mental health). In
other words, with respect to the group of individuals with
mental health problems the present analyses were afflicted
with a statistical power problem. This poses a major di-
lemma because while KiGGS is a large population based
survey it appears as if for certain analyses even that size
may not have been sufficient to give the power necessary
for certain statistical tests. The number of valid inference-
based conclusions to be drawn is thus limited. However,
part of the results can be viewed in an exploratory fashion
offering ample scope for future research. For instance,
because of the large sample that is necessary to obtain a
sufficient number of individuals with mental health abnor-
malities it might be an option to recruit a sufficiently large
number of individuals with mental health abnormalities
and compare their HRQoL with a control group with no
mental health problems that is matched for all other char-
acteristics with the group with mental health problems.
Further, it has to be pointed out, that diagnostic informa-
tion was based on parent report of physician diagnosed
atopic disease, which poses the typical problems self-report
can be afflicted with (see limitations below).
A main finding of the present analyses is that any of
the three atopic conditions impacts on HRQoL in
Table 2 Analyses of impact of atopic condition (within past 4 weeks and 12 months) on total and subscales of KINDL-R
stratified by mental health and controlled for presence of other atopic condition as well as age, gender, origin, ses,
overweight and allergic sensitisation
Within past 4 weeks Within past 12 months
SDQ = 0 SDQ = 1 SDQ = 2 SDQ = 0 SDQ = 1 SDQ = 2
(n = 5149) (n = 536) (n = 158) (n = 5120) (n = 536) (n = 158)
KINDL-R Total
Eczema −1.82* −0.98 2.80 −1.07 −0.03 2.28
Asthma 0.92 −1.49 3.04 0.08 −0.60 0.70
Hay fever −1.46* −3.98 −10.66 −1.14* −1.84 −1.63
KINDL-R Physical
Eczema −2.21* −5.43 10.47 −1.97 −5.19 7.49
Asthma −0.13 −7.56 4.56 −1.80 −4.79 1.29
Hay fever −4.96*** −3.30 −11.31 −2.44** −4.34 −2.23
KINDL-R Emotional well-being
Eczema −1.53 −3.89 1.69 −0.28 −0.69 2.87
Asthma −0.14 −2.34 6.82 −0.20 −2.07 5.57
Hay fever −0.31 −5.38 −19.07* −0.29 −0.63 −4.82
KINDL-R Self
Eczema −3.01* 3.93 −4.08 −1.10 6.39 −5.37
Asthma 1.39 −6.17 −1.37 0.49 −1.78 −6.12
Hay fever −0.67 0.05 −6.89 −1.21 −1.37 3.49
KINDL-R Family
Eczema −1.37 −2.13 10.44* −2.36* −1.09 6.52
Asthma 0.26 0.73 3.75 0.40 −1.09 0.29
Hay fever −1.65 −4.75 −8.12 −1.17 −1.17 −2.67
KINDL-R Friends
Eczema −0.60 1.69 3.26 0.41 2.08 6.65
Asthma 0.19 1.50 5.87 0.11 −0.81 4.55
Hay fever −1.30 −8.56 −4.88 −0.70 −5.30 −1.80
KINDL-R School
Eczema −2.17 −0.35 −4.91 −1.04 −2.00 −4.77
Asthma 3.85* 5.03 −0.44 1.27 6.69 −0.20
Hay fever −0.60 −0.52 −11.21 −1.22 2.56 −0.89
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, SDQ = 0: normal, SDQ = 1: borderline, SDQ = 2: abnormal mental health, numbers in table refer to unstandardised Beta
coefficients (B) that can be interpreted as increments in KINDL-R scores in individuals in whom the condition is present compared to those in whom the condition
is not present while holding all other variables constant.
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children and adolescents when no mental health prob-
lems are present. The specific impact of each condition
varies, however [see 21].
In the group with mental health abnormalities, eczema
paradoxically appears to have a positive effect on some
domains of HRQoL. Those with eczema within the past
four weeks had a significant 10 point increase in the
family relation domain. It may be that the presence of
eczema binds the family more closely together thus
overcoming the often destructive character of mental
health abnormality on family relations. Alternatively,
parents and siblings may be more accepting of a child’s
behaviour if it can be attributed to a physical rather than
a mental health problem which may in turn relax family
relations. Mental illness is still associated with substan-
tial stigma [39] and there is still a widespread assump-
tion that physical illness is more legitimate than mental
illness [40] and as thus relatives of sufferers may be
more accepting and more supportive. In other words,
children and adolescents with eczema may encounter
more support during flares from their families and thus
view the impact on the family not as impairing but as fa-
cilitating. More research, however, is necessary to disen-
tangle the exact dynamics behind this observation. A
similar but less pronounced trend was observed with re-
gard to asthma. The combination of acute asthma (past
four weeks) and mental health abnormalities was associ-
ated with better total and some subscale scores of
KINDL-R. However, the group size was again too small
for these effects to reach statistical significance. While
children and adolescents with asthma have been found
to be at increased risk for mental health problems, par-
ticularly internalising problems (emotional well-being)
[41] leading to suggestions of accumulative risks for
HRQoL-impairments [42] it may also be necessary to
look at the amount of external resources available (e.g.
social support). It may be that these resources are pro-
vided more when asthma and mental health problems
coincide and then HRQoL is not affected in cumulative
fashion but support can help individuals better come to
terms with both conditions but again, more research is
needed.
Acute hay fever (past four weeks), however, was asso-
ciated with stronger HRQoL-impairment in individuals
with mental health problems in comparison to those
with no such problems. For this disease it appears as if
the burden is increased when it is paired with mental
health problems. Nevertheless, perhaps due to limited
power, only the effect on emotional well-being reached
statistical significance but the decrements in HRQoL
were quite substantial. When hay fever attacks occur in
an individual already affected by mental health problems
these additional problems may have an accumulative
character unlike what was observed with regard to
eczema or asthma. Hay fever is a seasonally occurring
condition in contrast to eczema which although cha-
racterised by flares can appear all year round. The modi-
fying effect of mental health was mainly limited to acute
hay fever (past four weeks). No substantial or significant
effects were observed for hay fever within the past 12
months. As hay fever is highly seasonal this finding indi-
cates that most of the effect of hay fever on HRQoL is
immediate rather than persistent over time, irrespective
of the presence of additional mental health problems.
In addition to the discussed power issue, the findings
also need to be viewed in light of how valid atopic disease
and mental health were assessed in this study. Both were
assessed by self-report which is often afflicted with an in-
formation bias due to the well-known problems of social
desirability or memory distortion. Moreover, there is also
the problem of how constructs are operationalised. For in-
stance, while the SDQ is widely used it has to be borne in
mind that it is after all a screening instrument for mental
health status and secondly that concerns have been raised
with regard to misclassification resulting from inadequate
validity [37,38].
Conclusion
While it is generally believed that mental health problems
accentuate the relationship between chronic conditions
and HRQoL the present analyses found a diverse pattern
of relationships between any of three atopic conditions on
HRQoL when analyses were conducted separately as a
function of concurrent mental health problems. Future
studies should not only consider any joint effects of several
diseases and concurrent mental health problems, but also
what extra-personal resources are available and how they
may influence the impact of the atopic condition on
HRQoL in order to draw a clearer picture of how combi-
nations of conditions influence HRQoL differently.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
UM and CA devised the conception and design of the study. Statistical
analyses were carried out by UM. The interpretation of the findings occurred
co-jointly between UM and CA. The manuscript was drafted by UM. UM and
CA critically revised the manuscript for important intellectual content. Both
authors gave their final approval of the version to be published/submitted.
Acknowledgements
We thank the Robert-Koch-Institut, Berlin very much, for making the data
available as a public-use file. We thank all the children/adolescents and their
parents for the time and efforts they dedicated to taking part in this study.
Author details
1Department of Clinical Social Medicine, Occupational and Environmental
Dermatology, University Hospital Heidelberg, University of Heidelberg,
Thibautstrasse 3, 69115, Heidelberg, Germany. 2Medical Sociology, Institute of
Epidemiology and Preventive Medicine, University of Regensburg,
Heidelberg, Germany.
Matterne and Apfelbacher Health and Quality of Life Outcomes 2013, 11:115 Page 6 of 7
http://www.hqlo.com/content/11/1/115
Received: 15 October 2012 Accepted: 5 July 2013
Published: 8 July 2013
References
1. Stone KD: Atopic diseases of childhood. Curr Opin Pediatr 2003, 15:495–511.
2. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A:
Investigating international time trends in the incidence and prevalence
of atopic eczema 1990–2010: a systematic review of epidemiological
studies. PLoS One 2012, 7:e39803.
3. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI: Global
variations in prevalence of eczema symptoms in children from ISAAC
Phase Three. J Allergy Clin Immunol 2009, 124:1251–1258. e1223.
4. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From
bronchoconstriction to airways inflammation and remodeling.
Am J Respir Crit Care Med 2000, 161:1720–1745.
5. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its
impact on asthma. J Allergy Clin Immunol 2001, 108:S147–334.
6. McNeill G, Tagiyeva N, Aucott L, Russell G, Helms PJ: Changes in the
prevalence of asthma, eczema and hay fever in pre-pubertal children:
a 40-year perspective. Paediatr Perinat Epidemiol 2009, 23:506–512.
7. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J: Global
map of the prevalence of symptoms of rhinoconjunctivitis in children:
The International Study of Asthma and Allergies in Childhood (ISAAC)
Phase Three. Allergy 2009, 64:123–148.
8. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S: Global variation in
the prevalence and severity of asthma symptoms: phase three of the
International Study of Asthma and Allergies in Childhood (ISAAC).
Thorax 2009, 64:476–483.
9. Grammatikos AP: The genetic and environmental basis of atopic diseases.
Ann Med 2008, 40:482–495.
10. von Kobyletzki LB, Bornehag CG, Hasselgren M, Larsson M, Boman
Lindstrom C, Svensson A: Eczema in early childhood is strongly
associated with the development of asthma and rhinitis in a prospective
cohort. BMC Dermatol 2012, 12:11.
11. Marklund B, Ahlstedt S, Nordstrom G: Health-related quality of life among
adolescents with allergy-like conditions - with emphasis on food
hypersensitivity. Health Qual Life Outcomes 2004, 2:65.
12. Chamlin SL: The psychosocial burden of childhood atopic dermatitis.
Dermatol Ther 2006, 19:104–107.
13. O'Connell EJ: The burden of atopy and asthma in children. Allergy 2004,
59(Suppl 78):7–11.
14. Baiardini I, Braido F, Brandi S, Canonica GW: Allergic diseases and their
impact on quality of life. Ann Allergy Asthma Immunol 2006, 97:419–428.
quiz 429–430, 476.
15. Varni JW, Burwinkle TM, Lane MM: Health-related quality of life
measurement in pediatric clinical practice: an appraisal and precept for
future research and application. Health Qual Life Outcomes 2005, 3:34.
16. Lien L, Green K, Thoresen M, Bjertness E: Atopic conditions and mental
health problems: a 3-year follow-up study. Eur Child Adolesc Psychiatry
2010, 19:705–713.
17. Hasler G, Gergen PJ, Kleinbaum DG, Ajdacic V, Gamma A, Eich D, Rossler W,
Angst J: Asthma and panic in young adults: a 20-year prospective
community study. Am J Respir Crit Care Med 2005, 171:1224–1230.
18. Goodwin RD: Self-reported hay fever and panic attacks in the
community. Ann Allergy Asthma Immunol 2002, 88:556–559.
19. Wamboldt MZ, Hewitt JK, Schmitz S, Wamboldt FS, Räsänen M, Koskenvuo
M, Romanov K, Varjonen J, Kaprio J: Familial association between allergic
disorders and depression in adult Finnish twins. Am J Med Genet 2000,
96:146–153.
20. Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M: Psychiatric
comorbidity in adult eczema. Br J Dermatol 2009, 161:878–883.
21. Matterne U, Schmitt J, Diepgen TL, Apfelbacher C: Children and
adolescents' health-related quality of life in relation to eczema, asthma
and hay fever: results from a population-based cross-sectional study.
Qual Life Res 2011, 20:1295–1305.
22. Mok C, Lok E, Cheung E: Concurrent psychiatric disorders are associated
with significantly poorer quality of life in patients with rheumatoid
arthritis. Scand J Rheumatol 2012, 41:253–259.
23. Mannucci E, Petroni ML, Villanova N, Rotella CM, Apolone G, Marchesini G:
Clinical and psychological correlates of health-related quality of life in
obese patients. Health Qual Life Outcomes 2010, 8:90.
24. Uguz F, Engin B, Yilmaz E: Quality of life in patients with chronic
idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders.
Gen Hosp Psychiatry 2008, 30:453–457.
25. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and
chronic obstructive pulmonary disease: effect on mortality, hospital
readmission, symptom burden, functional status, and quality of life.
Arch Intern Med 2007, 167:60–67.
26. Kessler RC, Ormel J, Demler O, Stang PE: Comorbid mental disorders
account for the role impairment of commonly occurring chronic physical
disorders: results from the National Comorbidity Survey. J Occup Environ
Med 2003, 45:1257–1266.
27. Robert-Koch-Institut: Public-Use-File KiGGS. Berlin: Kinder und
Jugendgesundheitssurvey 2003–2006; 2008.
28. Kurth BM, Kamtsiuris P, Holling H, Schlaud M, Dolle R, Ellert U, Kahl H, Knopf
H, Lange M, Mensink GB, et al: The challenge of comprehensively
mapping children's health in a nation-wide health survey: design of the
German KiGGS-Study. BMC Publ Health 2008, 8:196.
29. Kamtsiuris P, Lange M, Schaffrath Rosario A: Der Kinder- und
Jugendgesundheitssurvey (KiGGS): Stichprobendesign, Response und
Nonresponse-Analyse [The German Health Interview and Examination
Survey for Children and Adolescents (KiGGS): Sample design, response
and nonresponse analysis]. Bundesgesundheitsblatt Gesundheitsforschung
Gesundheitsschutz 2007, 50:547–556.
30. Ravens-Sieberer U, Bullinger M: Assessing health-related quality of life in
chronically ill children with the German KINDL: first psychometric and
content analytical results. Qual Life Res 1998, 7:399–407.
31. Erhart M, Ellert U, Kurth BM, Ravens-Sieberer U: Measuring adolescents'
HRQoL via self reports and parent proxy reports: an evaluation of the
psychometric properties of both versions of the KINDL-R instrument.
Health Qual Life Outcomes 2009, 7:77.
32. Schlaud M, Atzpodien K, Thierfelder W: Allergic diseases. Results from the
German Health Interview and Examination Survey for Children and
Adolescents (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung
Gesundheitsschutz 2007, 50:701–710.
33. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von
Hippel A, Jaeger U, Johnsen D, Korte W, et al: Percentiles of body mass
index in children and adolescents evaluated from different regional
German studies. Monatsschr Kinderheilkd 2001, 149:807–818.
34. Winkler J, Stolzenberg H: Social class index in the Federal Health Survey.
Gesundheitswesen 1999, 61(2):178–183.
35. Goodman R, Meltzer H, Bailey V: The Strengths and Difficulties
Questionnaire: a pilot study on the validity of the self-report version.
Eur Child Adolesc Psychiatry 1998, 7:125–130.
36. Goodman R: The Strengths and Difficulties Questionnaire: a research
note. J Child Psychol Psychiatry 1997, 38:581–586.
37. Van Roy B, Veenstra M, Clench-Aas J: Construct validity of the five-factor
Strengths and Difficulties Questionnaire (SDQ) in pre-, early, and late
adolescence. J Child Psychol Psychiatry 2008, 49:1304–1312.
38. Goodman A, Heiervang E, Fleitlich-Bilyk B, Alyahri A, Patel V, Mullick MS,
Slobodskaya H, Dos Santos DN, Goodman R: Cross-national differences
in questionnaires do not necessarily reflect comparable differences
in disorder prevalence. Soc Psychiatry Psychiatr Epidemiol 2012,
47:1321–1331.
39. Hinshaw SP, Stier A: Stigma as related to mental disorders. Annu Rev Clin
Psychol 2008, 4:367–393.
40. Kendell RE: The distinction between mental and physical illness.
Br J Psychiatry 2001, 178:490–493.
41. Calam R, Gregg L, Goodman R: Psychological adjustment and asthma in
children and adolescents: the UK Nationwide Mental Health Survey.
Psychosom Med 2005, 67:105–110.
42. Goldbeck L, Koffmane K, Lecheler J, Thiessen K, Fegert JM: Disease severity,
mental health, and quality of life of children and adolescents with
asthma. Pediatr Pulmonol 2007, 42:15–22.
doi:10.1186/1477-7525-11-115
Cite this article as: Matterne and Apfelbacher: Is the impact of atopic
disease on children and adolescents’ health related quality of life
modified by mental health? Results from a population-based cross-
sectional study. Health and Quality of Life Outcomes 2013 11:115.
Matterne and Apfelbacher Health and Quality of Life Outcomes 2013, 11:115 Page 7 of 7
http://www.hqlo.com/content/11/1/115
